Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder.

Cohn JB, Collins G, Ashbrook E, Wernicke JF.

Int Clin Psychopharmacol. 1989 Oct;4(4):313-22.

PMID:
2607128
[PubMed - indexed for MEDLINE]
2.

A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.

Cohn JB, Wilcox C.

J Clin Psychiatry. 1985 Mar;46(3 Pt 2):26-31.

PMID:
3882677
[PubMed - indexed for MEDLINE]
3.

Fluoxetine in depressed patients: a comparison with imipramine.

Bremner JD.

J Clin Psychiatry. 1984 Oct;45(10):414-9.

PMID:
6384203
[PubMed - indexed for MEDLINE]
4.

A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.

Stark P, Hardison CD.

J Clin Psychiatry. 1985 Mar;46(3 Pt 2):53-8.

PMID:
3882682
[PubMed - indexed for MEDLINE]
5.

A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.

Feighner JP, Boyer WF, Merideth CH, Hendrickson GG.

Int Clin Psychopharmacol. 1989 Apr;4(2):127-34.

PMID:
2663975
[PubMed - indexed for MEDLINE]
6.

Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.

Keck PE Jr, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M.

J Clin Psychiatry. 2005 May;66(5):611-6.

PMID:
15889948
[PubMed - indexed for MEDLINE]
7.

Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.

Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.

J Clin Psychiatry. 2001 Apr;62(4):273-81.

PMID:
11379842
[PubMed - indexed for MEDLINE]
8.

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2003 Nov;60(11):1079-88. Erratum in: Arch Gen Psychiatry. 2004 Feb;61(2):176.

PMID:
14609883
[PubMed - indexed for MEDLINE]
9.

A double-blind, controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders.

Merideth CH, Feighner JP.

Acta Psychiatr Scand Suppl. 1983;308:70-9.

PMID:
6230897
[PubMed - indexed for MEDLINE]
10.

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.

Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD.

Am J Psychiatry. 2001 Jun;158(6):906-12.

PMID:
11384898
[PubMed - indexed for MEDLINE]
11.

Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study.

Amsterdam JD, Shults J.

Int Clin Psychopharmacol. 2005 Sep;20(5):257-64.

PMID:
16096516
[PubMed - indexed for MEDLINE]
12.

A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder.

Nielsen BM, Behnke K, Arup P, Christiansen PE, Geisler A, Ipsen E, Maach-Møller B, Ohrberg SC.

Acta Psychiatr Scand. 1993 Apr;87(4):269-72.

PMID:
8488748
[PubMed - indexed for MEDLINE]
13.

A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.

Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vågerö M, Svensson K.

J Clin Psychiatry. 2005 Jan;66(1):111-21.

PMID:
15669897
[PubMed - indexed for MEDLINE]
14.

Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.

Judd LL, Rapaport MH, Yonkers KA, Rush AJ, Frank E, Thase ME, Kupfer DJ, Plewes JM, Schettler PJ, Tollefson G.

Am J Psychiatry. 2004 Oct;161(10):1864-71.

PMID:
15465984
[PubMed - indexed for MEDLINE]
15.

A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia.

Heiligenstein JH, Tollefson GD, Faries DE.

Int Clin Psychopharmacol. 1993 Winter;8(4):247-51.

PMID:
8277143
[PubMed - indexed for MEDLINE]
16.

Placebo response in depression: a search for predictors.

Brown WA, Dornseif BE, Wernicke JF.

Psychiatry Res. 1988 Dec;26(3):259-64.

PMID:
3065807
[PubMed - indexed for MEDLINE]
17.

Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.

Byerley WF, Reimherr FW, Wood DR, Grosser BI.

J Clin Psychopharmacol. 1988 Apr;8(2):112-5.

PMID:
3286684
[PubMed - indexed for MEDLINE]
18.

Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial.

Beasley CM Jr, Holman SL, Potvin JH.

Ann Clin Psychiatry. 1993 Sep;5(3):199-207.

PMID:
8281243
[PubMed - indexed for MEDLINE]
19.

Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.

Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A.

Arch Gen Psychiatry. 1982 Sep;39(9):1065-9.

PMID:
6810839
[PubMed - indexed for MEDLINE]
20.

A double-blind comparison of nefazodone, imipramine, and placebo in major depression.

Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.

J Clin Psychiatry. 1994 Jun;55(6):234-41.

PMID:
8071277
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk